Invivyd (Nasdaq: IVVD) warned over sub-$1 share price and listing risk
Rhea-AI Filing Summary
Invivyd, Inc. disclosed that it received a Nasdaq deficiency letter because its common stock failed to meet the $1.00 per share minimum bid price requirement for 30 consecutive business days for listing on The Nasdaq Global Market.
The company has until January 19, 2027 to regain compliance by having a closing bid of at least $1.00 for a minimum of ten consecutive business days, subject to Nasdaq’s discretion to extend that period. If compliance is not regained, Invivyd may seek a second 180‑day compliance period by transferring to the Nasdaq Capital Market and meeting other listing criteria, but its stock could ultimately be subject to delisting, with only a right to appeal to a Nasdaq Hearings Panel. Invivyd plans to monitor its share price and consider available options but provides no assurance it will regain compliance.
Positive
- None.
Negative
- Nasdaq listing at risk after 30 days below $1 bid.
8-K Event Classification
Item 3.01 — Notice of Delisting or Failure to Satisfy a Continued Listing Rule or Standard; Transfer of Listing
1 item
Item 3.01
Notice of Delisting or Failure to Satisfy a Continued Listing Rule or Standard; Transfer of Listing
Securities
The company received a delisting notice or transferred its listing to a different exchange.
Key Figures
Minimum bid price requirement: $1.00 per share
Non-compliance period: 30 consecutive business days
Initial compliance deadline: January 19, 2027
+1 more
4 metrics
Minimum bid price requirement
$1.00 per share
Threshold for continued listing on The Nasdaq Global Market under Nasdaq Listing Rule 5450(a)(1).
Non-compliance period
30 consecutive business days
Period during which Invivyd’s common stock closed below the $1.00 minimum bid price.
Initial compliance deadline
January 19, 2027
Date by which Invivyd must regain compliance with Nasdaq’s minimum bid price requirement.
Potential second compliance period
180 calendar days
Additional time that may be granted if Invivyd transfers to the Nasdaq Capital Market and meets other listing criteria.
Key Terms
Minimum Bid Price Requirement, Nasdaq Global Market, Nasdaq Capital Market, Nasdaq Listing Rule 5450(a)(1), +2 more
6 terms
Minimum Bid Price Requirement regulatory
"regain compliance with the Minimum Bid Price Requirement"
A minimum bid price requirement is a rule that a stock must trade above a set price for a specified period to stay listed on an exchange. It matters to investors because falling below that threshold can trigger warnings or removal from the exchange, which can cut liquidity, reduce visibility, and often lead to sharper declines in share value—think of it like a venue’s minimum dress code that, if not met, can bar a performer from the stage.
Nasdaq Global Market regulatory
"required for continued listing on The Nasdaq Global Market"
The Nasdaq Global Market is a section of the stock exchange where larger, well-established companies are listed and publicly traded. It functions like a marketplace where investors can buy and sell shares of these companies, providing them with access to capital and opportunities for growth. Its role is important because it helps investors identify and invest in reputable companies with strong financial backgrounds.
Nasdaq Capital Market regulatory
"required to transfer to The Nasdaq Capital Market"
The Nasdaq Capital Market is a platform where smaller, emerging companies can list their shares for trading by investors. It provides these companies with access to funding and visibility, helping them grow, much like a local marketplace where new vendors can introduce their products to potential customers. For investors, it offers opportunities to discover early-stage companies with growth potential.
Nasdaq Listing Rule 5450(a)(1) regulatory
"required for continued listing pursuant to Nasdaq Listing Rule 5450(a)(1)"
Nasdaq Listing Rule 5450(a)(1) is a continued-listing standard that sets a minimum share price companies must maintain to remain listed on the Nasdaq market—commonly a $1.00 per-share threshold. Investors care because falling below that floor can trigger a compliance review and possible delisting, which is like failing a minimum grade and losing access to the public market; delisting can reduce liquidity, visibility and the ability to raise capital.
Nasdaq Listing Rule 5810(c)(3)(A) regulatory
"In accordance with Nasdaq Listing Rule 5810(c)(3)(A)"
Nasdaq Hearings Panel regulatory
"may appeal the delisting determination to a Nasdaq Hearings Panel"
A Nasdaq hearings panel is a group of experts that reviews cases when a company's stock listing is at risk of being removed from the exchange. They evaluate whether the company has met certain standards and determine if it can keep trading on Nasdaq. This process matters to investors because it can affect a company's ability to raise money and maintain credibility in the market.
AI-generated analysis. How Rhea-AI works. Not financial advice.
FAQ
What Nasdaq notice did Invivyd (IVVD) receive about its stock price?
Invivyd received a Nasdaq deficiency letter stating its common stock closed below the $1.00 minimum bid price for 30 consecutive business days, putting its Global Market listing at risk if compliance is not regained.
By when must Invivyd (IVVD) regain compliance with Nasdaq’s $1.00 bid rule?
Invivyd has until January 19, 2027 to regain compliance by maintaining a closing bid of at least $1.00 per share for a minimum of ten consecutive business days during this initial compliance period.
Can Invivyd (IVVD) obtain more time beyond January 19, 2027 to fix the deficiency?
If Invivyd is still noncompliant by January 19, 2027, it may qualify for an additional 180 calendar day period by transferring to the Nasdaq Capital Market and meeting all other initial listing and market value requirements.
What happens if Invivyd (IVVD) cannot meet Nasdaq’s minimum bid price requirements?
If Invivyd fails to regain compliance within the allowed period(s), Nasdaq Staff may move to delist the common stock. Invivyd would receive written notice and could appeal the determination to a Nasdaq Hearings Panel, with no assurance of success.
How does Invivyd (IVVD) plan to address the Nasdaq bid price deficiency?
Invivyd intends to actively monitor the closing bid price of its common stock and consider available options to regain compliance with the minimum bid price requirement, while cautioning that there is no assurance these efforts will succeed.